Physician

Ramesh V Patel, M.D.

According to 2025 Medicare claims, Ramesh Patel, M.D. (NPI: 1396744033) practices hematology/oncology in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Christian, KY. This provider's primary affiliated billing organization is JENNIE STUART MEDICAL CENTER INC (NPI: 1588384671; TIN: 61-0482973) and primary practice location at 42240-6300. Patel is affiliated with the Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 361 traditional Medicare patients, billed 1,020 HCPCS/CPT codes, and received $64,304 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 729 prescription claims across 140 beneficiaries totaling $3,094,747 in drug costs, led by Imbruvica (Ibrutinib). 2019 DME data shows 11 claims. Open Payments data shows 11 records totaling $244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $2,210,866 to $64,304. In contrast, Part D prescription costs have moved sharply higher in recent years, from $351,182 to $3,094,747. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	871	184,523	$2,210,866
2016	922	258,652	$2,730,573
2017	880	162,546	$2,209,675
2018	887	188,001	$2,527,770
2019	865	107,269	$1,675,344
2020	543	12,868	$154,278
2021	500	9,509	$127,501
2022	453	6,220	$107,399
2023	405	2,172	$67,412
2024	361	1,020	$64,304

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	638	$351,182
2016	181	755	$718,611
2017	144	575	$1,203,261
2018	115	483	$1,067,549
2019	89	334	$913,183
2020	107	406	$845,846
2021	115	476	$1,832,041
2022	122	553	$2,106,274
2023	136	658	$3,112,678
2024	140	729	$3,094,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	116	$6,828
2016	N/R	101	$4,410
2017	N/R	11	$751
2018	N/R	N/R	N/R
2019	N/R	11	$711
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	24	24	$139
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	115	170	$108
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	13	13	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	539	$72
36415	Insertion of needle into vein for collection of blood sample	167	183	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	30	840	$490,507
Revlimid	Lenalidomide	24	672	$408,585
Tukysa	Tucatinib	12	360	$313,711
Alecensa	Alectinib Hcl	15	450	$260,840
Verzenio	Abemaciclib	16	448	$246,538

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$244	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramesh V. Patel, M.D.?

Tedicare shows public-source Medicare data for Ramesh V. Patel, M.D. (NPI 1396744033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramesh V. Patel, M.D. have ACO affiliation data?

Ramesh V. Patel, M.D. is shown with ACO affiliation data for Imperium Clinical Partners (MSSP, ACO ID A4945).

What billing organization is linked to Ramesh V. Patel, M.D.?

Ramesh V. Patel, M.D. is linked to JENNIE STUART MEDICAL CENTER INC (billing NPI 1588384671) in the available physician profile data.

Does Ramesh V. Patel, M.D. have Open Payments data?

Ramesh V. Patel, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.